Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant

Yongjun Yu,1 Hai V Ngo,1 Gang Jin,1 Phuong HL Tran,2 Thao TD Tran,3,4 Van Hong Nguyen,5 Chulhun Park,6 Beom-Jin Lee1 1College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea; 2Deakin University, School of Medicine, Geelong, Australia; 3Institute of Research and Development, Duy Tan Uni...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu Y, Ngo HV, Jin G, Tran PHL, Tran TTD, Nguyen VH, Park C, Lee BJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	albumin-oleic acid conjugate self-assembled nanonization solvent type in situ forming implant solvent exchange controlled release Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/bb50e9f2c02f4b3fa7ec883a793f47d6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bb50e9f2c02f4b3fa7ec883a793f47d6
record_format	dspace
spelling	oai:doaj.org-article:bb50e9f2c02f4b3fa7ec883a793f47d62021-12-02T17:20:42ZDouble-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant1178-2013https://doaj.org/article/bb50e9f2c02f4b3fa7ec883a793f47d62021-04-01T00:00:00Zhttps://www.dovepress.com/double-controlled-release-of-poorly-water-soluble-paliperidone-palmita-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yongjun Yu,1 Hai V Ngo,1 Gang Jin,1 Phuong HL Tran,2 Thao TD Tran,3,4 Van Hong Nguyen,5 Chulhun Park,6 Beom-Jin Lee1 1College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea; 2Deakin University, School of Medicine, Geelong, Australia; 3Institute of Research and Development, Duy Tan University, Danang, 550000, Vietnam; 4The Faculty of Pharmacy, Duy Tan University, Danang, 550000, Vietnam; 5Pharmaceutical Engineering Laboratory, Biomedical Engineering Department, International University, Vietnam National University, Ho Chi Minh City, 70000, Vietnam; 6Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, CanadaCorrespondence: Beom-Jin LeeBioavailability Control Laboratory, College of Pharmacy, Ajou University, Suwon, 16499, Republic of KoreaTel +82312193442Fax +82312193435Email bjl@ajou.ac.krPurpose: To investigate the effects of solvents on the formation of self-assembled nanonization of albumin-oleic acid conjugates (AOCs) using a solvent exchange mechanism for the construction of in situ forming implants (ISFI).Methods: A poorly water-soluble drug, paliperidone palmitate (PPP), was chosen as the model drug. AOC was synthesized with the 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) reaction. Dichloromethane, tetrahydrofuran, ethanol, N-methyl-2-pyrrolidone, dimethyl sulfoxide, and deionized water were selected to investigate the formation of self-assembled AOC nanoparticles (AONs). The volume ratios of organic solvents against water could determine the miscibility, injectability, and in situ nanonizing capability without aggregation.Results: As the polarity of the organic solvents increased, the AONs exhibited a spherical shape, and the larger the volume of the solvent, the smaller the size of the AONs. To use AOC in ISFI for controlled release of PPP, poly(d,l-lactide-co-glycolide) (PLGA) was combined with the AOC in 2 mL of N-methyl-2-pyrrolidone and water solution (1.8/0.2 ratio). The release rates of all formulations exhibited similar curve patterns overall but were more controlled in decreasing order as follows: AOC, PLGA, and AOC/PLGA for 14 days.Conclusion: A combined formulation of AOC and PLGA was found to effectively control the initial burst release of the drug.Keywords: albumin-oleic acid conjugate, self-assembled nanonization, solvent type, in situ forming implant, solvent exchange, controlled releaseYu YNgo HVJin GTran PHLTran TTDNguyen VHPark CLee BJDove Medical Pressarticlealbumin-oleic acid conjugateself-assembled nanonizationsolvent typein situ forming implantsolvent exchangecontrolled releaseMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 2819-2831 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	albumin-oleic acid conjugate self-assembled nanonization solvent type in situ forming implant solvent exchange controlled release Medicine (General) R5-920
spellingShingle	albumin-oleic acid conjugate self-assembled nanonization solvent type in situ forming implant solvent exchange controlled release Medicine (General) R5-920 Yu Y Ngo HV Jin G Tran PHL Tran TTD Nguyen VH Park C Lee BJ Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant
description	Yongjun Yu,1 Hai V Ngo,1 Gang Jin,1 Phuong HL Tran,2 Thao TD Tran,3,4 Van Hong Nguyen,5 Chulhun Park,6 Beom-Jin Lee1 1College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea; 2Deakin University, School of Medicine, Geelong, Australia; 3Institute of Research and Development, Duy Tan University, Danang, 550000, Vietnam; 4The Faculty of Pharmacy, Duy Tan University, Danang, 550000, Vietnam; 5Pharmaceutical Engineering Laboratory, Biomedical Engineering Department, International University, Vietnam National University, Ho Chi Minh City, 70000, Vietnam; 6Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, CanadaCorrespondence: Beom-Jin LeeBioavailability Control Laboratory, College of Pharmacy, Ajou University, Suwon, 16499, Republic of KoreaTel +82312193442Fax +82312193435Email bjl@ajou.ac.krPurpose: To investigate the effects of solvents on the formation of self-assembled nanonization of albumin-oleic acid conjugates (AOCs) using a solvent exchange mechanism for the construction of in situ forming implants (ISFI).Methods: A poorly water-soluble drug, paliperidone palmitate (PPP), was chosen as the model drug. AOC was synthesized with the 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) reaction. Dichloromethane, tetrahydrofuran, ethanol, N-methyl-2-pyrrolidone, dimethyl sulfoxide, and deionized water were selected to investigate the formation of self-assembled AOC nanoparticles (AONs). The volume ratios of organic solvents against water could determine the miscibility, injectability, and in situ nanonizing capability without aggregation.Results: As the polarity of the organic solvents increased, the AONs exhibited a spherical shape, and the larger the volume of the solvent, the smaller the size of the AONs. To use AOC in ISFI for controlled release of PPP, poly(d,l-lactide-co-glycolide) (PLGA) was combined with the AOC in 2 mL of N-methyl-2-pyrrolidone and water solution (1.8/0.2 ratio). The release rates of all formulations exhibited similar curve patterns overall but were more controlled in decreasing order as follows: AOC, PLGA, and AOC/PLGA for 14 days.Conclusion: A combined formulation of AOC and PLGA was found to effectively control the initial burst release of the drug.Keywords: albumin-oleic acid conjugate, self-assembled nanonization, solvent type, in situ forming implant, solvent exchange, controlled release
format	article
author	Yu Y Ngo HV Jin G Tran PHL Tran TTD Nguyen VH Park C Lee BJ
author_facet	Yu Y Ngo HV Jin G Tran PHL Tran TTD Nguyen VH Park C Lee BJ
author_sort	Yu Y
title	Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant
title_short	Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant
title_full	Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant
title_fullStr	Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant
title_full_unstemmed	Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant
title_sort	double-controlled release of poorly water-soluble paliperidone palmitate from self-assembled albumin-oleic acid nanoparticles in plga in situ forming implant
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/bb50e9f2c02f4b3fa7ec883a793f47d6
work_keys_str_mv	AT yuy doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT ngohv doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT jing doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT tranphl doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT tranttd doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT nguyenvh doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT parkc doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant AT leebj doublecontrolledreleaseofpoorlywatersolublepaliperidonepalmitatefromselfassembledalbuminoleicacidnanoparticlesinplgainsituformingimplant
_version_	1718381047107813376

Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant

Ejemplares similares